Product Review: Tecentriq in locally advanced or metastatic urothelial carcinoma

In this review:

The aim of this review is to describe important safety and efficacy data for atezolizumab in
patients with locally advanced or metastatic urothelial carcinoma. This publication has been
commissioned by Roche Products (New Zealand) Limited.

Please login below to download this issue (PDF)

Subscribe